140 related articles for article (PubMed ID: 19735101)
21. Conventional four-field pelvic radiotherapy technique without CT treatment planning in cancer of the cervix: potential geographic miss.
Kim RY; McGinnis LS; Spencer SA; Meredith RF; Jennelle RL; Salter MM
Radiother Oncol; 1994 Feb; 30(2):140-5. PubMed ID: 8184111
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
23. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
[TBL] [Abstract][Full Text] [Related]
24. [Incidence and influencing factors of distal external iliac lymph node metastasis in early cervical cancer].
Yin Y; Sheng X; Li X; Li D; Han X; Zhang X; Zhang T
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):457-60. PubMed ID: 25241790
[TBL] [Abstract][Full Text] [Related]
25. A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.
; Toita T; Ohno T; Kaneyasu Y; Uno T; Yoshimura R; Kodaira T; Furutani K; Kasuya G; Ishikura S; Kamura T; Hiraoka M
Jpn J Clin Oncol; 2010 May; 40(5):456-63. PubMed ID: 20133334
[TBL] [Abstract][Full Text] [Related]
26. Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer.
Kasuya G; Toita T; Furutani K; Kodaira T; Ohno T; Kaneyasu Y; Yoshimura R; Uno T; Yogi A; Ishikura S; Hiraoka M
Radiat Oncol; 2013 Jun; 8():139. PubMed ID: 23758698
[TBL] [Abstract][Full Text] [Related]
27. Gynecologic radiotherapy fields defined by intraoperative measurements.
Greer BE; Koh WJ; Figge DC; Russell AH; Cain JM; Tamimi HK
Gynecol Oncol; 1990 Sep; 38(3):421-4. PubMed ID: 2227555
[TBL] [Abstract][Full Text] [Related]
28. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
[TBL] [Abstract][Full Text] [Related]
29. Spectral CT imaging in cervical computed tomography angiography: comparison of spectral CT monochromatic imaging and conventional CT polychromatic imaging.
Du X; Yang X; Cheng W; Huang N; Zhou L; Zhang J
Int J Clin Pract; 2016 Sep; 70 Suppl 9B():B44-9. PubMed ID: 27577513
[TBL] [Abstract][Full Text] [Related]
30. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review.
Buda A; Elisei F; Arosio M; Dolci C; Signorelli M; Perego P; Giuliani D; Recalcati D; Cattoretti G; Milani R; Messa C
Int J Gynecol Cancer; 2012 Jun; 22(5):830-5. PubMed ID: 22617479
[TBL] [Abstract][Full Text] [Related]
31. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
[TBL] [Abstract][Full Text] [Related]
32. Vessel-contouring-based pelvic radiotherapy in patients with uterine cervical cancer.
Uno T; Isobe K; Ueno N; Kobayashi H; Sanayama Y; Mitsuhashi A; Shozu M; Ito H
Jpn J Clin Oncol; 2009 Jun; 39(6):376-80. PubMed ID: 19351660
[TBL] [Abstract][Full Text] [Related]
33. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
[TBL] [Abstract][Full Text] [Related]
34. Delineating the relationship between Point A prescription dose and pelvic lymph node doses in intracavitary high-dose-rate brachytherapy treatment of cervical cancer for use in low- and middle-income countries.
Weaver J; Harmon G; Harkenrider MM; Surucu M; Wood A; Alite F; Small W
Brachytherapy; 2018; 17(1):201-207. PubMed ID: 29066085
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation.
Portelance L; Chao KS; Grigsby PW; Bennet H; Low D
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):261-6. PubMed ID: 11516876
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of geographic miss when using conventional four field radiotherapy technique in treatment of locally advanced carcinoma cervix.
Gulia A; Patel FD; Santam C; Bhavana R; Reena K; Sharma SC
Indian J Cancer; 2016; 53(1):80-5. PubMed ID: 27146749
[TBL] [Abstract][Full Text] [Related]
37. Distribution pattern of lymph node metastases and its implication in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with stage IA to IIA cervical cancer.
Li X; Yin Y; Sheng X; Han X; Sun L; Lu C; Wang X
Radiat Oncol; 2015 Feb; 10():40. PubMed ID: 25886535
[TBL] [Abstract][Full Text] [Related]
38. [The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].
Zhang HY; Sheng XG; Zhong Y; Ma ZF; Ma YB; Liu NF; Chen YT; Wang YY
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):452-5. PubMed ID: 19024522
[TBL] [Abstract][Full Text] [Related]
39. Comparison of standard and individually planned infradiaphragmatic fields in irradiation of retroperitoneal lymph nodes.
Nevinny-Stickel M; Ennemoser S; Sweeney R; Bangerl I; Zur Nedden D; Lukas P
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):147-51. PubMed ID: 10924984
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF
Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
